Ligand profile
88Q
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: A0A075B6I6
Identifiers
Database identifiers and provenance.
- Ligand ID
88Q- PDB
4aiz- UniProt (similar protein)
Q5NV90- Target protein
- A0A075B6I6
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 99.4
- −1 ≤ LogP ≤ 5 -1.21
- MW ≤ 500 Da 262.3
- LogP ≤ 5 -1.21
- H-bond donors ≤ 5 4
- H-bond acceptors ≤ 10 6
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 99.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C1C[C@@](CO[C@@H]1[C@@H]2CC[C@@](CO2)(CO)O)(CO)OC1C[C@@](CO[C@@H]1[C@@H]2CC[C@@](CO2)(CO)O)(CO)O
InChI=1S/C12H22O6/c13-5-11(15)3-1-9(17-7-11)10-2-4-12(16,6-14)8-18-10/h9-10,13-16H,1-8H2/t9-,10-,11-,12-/m0/s1InChI=1S/C12H22O6/c13-5-11(15)3-1-9(17-7-11)10-2-4-12(16,6-14)8-18-10/h9-10,13-16H,1-8H2/t9-,10-,11-,12-/m0/s1
FJMBBGDZFKPKCM-BJDJZHNGSA-NFJMBBGDZFKPKCM-BJDJZHNGSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ domain
- Source
- PDB
- Binding sites
- PF07686
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand 88Q →
- PDB RCSB structure 4aiz →
- UniProt UniProt Q5NV90 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “88Q”) →
Other ligands for this protein
Quick navigation to other ligands bound to A0A075B6I6.
PDB 54
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 29
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).